A promising new drug combination exploits a metabolic vulnerability in leukemia cells. Researchers have discovered a way to kill leukemia cells by forcing them to remain highly active even as their energy supply is disrupted. The experimental treatment has produced promising results in mice and patient-derived cancer cells, including a particularly aggressive form of the […]This is a curated summary.